| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.10433 |
| P8608 | Fatcat ID | release_qnc5camxy5bvtbplu7vtsolmlm |
| P698 | PubMed publication ID | 12209514 |
| P5875 | ResearchGate publication ID | 11178565 |
| P50 | author | Kjeld Søballe | Q41603042 |
| Michael Ulrich-Vinther | Q41603533 | ||
| P2093 | author name string | Regis J O'Keefe | |
| Mary B Goldring | |||
| Edward M Schwarz | |||
| Michael D Maloney | |||
| Michael Ulrich-Vinther | |||
| J Jeffrey Goater | |||
| P2860 | cites work | Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis | Q45739253 |
| Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist | Q45744151 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV. | Q45807702 | ||
| Gene therapy for rheumatic diseases | Q45855770 | ||
| The 2.2-kb promoter of cartilage-derived retinoic acid-sensitive protein controls gene expression in cartilage and embryonic mammary buds of transgenic mice. | Q52163195 | ||
| Regulation of the collagen II gene in vitro and in transgenic mice. | Q52242811 | ||
| Articular cartilage: injuries and potential for healing. | Q52532281 | ||
| Rheumatoid arthritis | Q74541001 | ||
| Gene therapy for rheumatoid arthritis | Q94030890 | ||
| Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors | Q24683259 | ||
| Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results | Q28137667 | ||
| Overview of treatment options for arthritis in the active patient | Q33535411 | ||
| Degradation and repair of articular cartilage | Q33753612 | ||
| Building a better vector: the manipulation of AAV virions | Q33928283 | ||
| Surgical alternatives for treatment of articular cartilage lesions. | Q33954881 | ||
| The adeno-associated virus vector for orthopaedic gene therapy. | Q34064835 | ||
| Adeno-associated virus vectors for gene therapy: more pros than cons? | Q34080580 | ||
| Gene therapy: promises and problems. | Q34101058 | ||
| Cartilage substitutes: overview of basic science and treatment options. | Q34138493 | ||
| Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis | Q34180331 | ||
| Management of osteochondral injuries of the knee | Q34277493 | ||
| Treatment of osteochondral injuries. Genetic engineering | Q34277509 | ||
| AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection | Q34486863 | ||
| Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus | Q36159178 | ||
| Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation | Q39602167 | ||
| Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis | Q40839721 | ||
| Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta | Q40848122 | ||
| Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver | Q41753510 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors | Q42525047 | ||
| Real-time single-molecule imaging of the infection pathway of an adeno-associated virus | Q43812869 | ||
| Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. | Q44956168 | ||
| P433 | issue | 8 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 2095-2104 | |
| P577 | publication date | 2002-08-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes | |
| P478 | volume | 46 |
| Q35090336 | Clinical potential and challenges of using genetically modified cells for articular cartilage repair |
| Q39241045 | Direct FGF-2 gene transfer via recombinant adeno-associated virus vectors stimulates cell proliferation, collagen production, and the repair of experimental lesions in the human ACL. |
| Q45874835 | Gene Delivery to Joints by Intra-articular Injection. |
| Q38526206 | Gene Therapy for Cartilage Repair |
| Q35629558 | Gene-based approaches for the repair of articular cartilage |
| Q45703658 | Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells |
| Q36780068 | Persistence, localization, and external control of transgene expression after single injection of adeno-associated virus into injured joints. |
| Q35617341 | Role of gene therapy in tissue engineering procedures in rheumatology: the use of animal models |
| Q36729692 | The use of recombinant adeno-associated virus for skeletal gene therapy |
| Q79882401 | [Tissue engineering for articular cartilage repair improved by gene transfer. Current concepts] |
Search more.